Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
In the second of two Asian Medtech Associations Regulatory Networking discussions this month, we focus on regulatory reforms in Singapore, and updates on Indonesia, the Philippines and Vietnam from recent regional regulatory meetings. This series is hosted by Medtech Insight and sponsored by the Asia Regulatory and Quality Consultancy (ARQon), the Asia Regulatory Professionals Association (ARPA), and Medtronic.
The second Asian Medtech Associations Regulatory Networking discussion focused on a range of regional issues, including the latest on-the-ground news and views. Hosted by Medtech Insight, and sponsored by the Asia Regulatory and Quality Consultancy (ARQon), the Asia Regulatory Professionals Association (ARPA) and Medtronic, this session is reported in two parts, with this first part focusing on Malaysia.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Forty-four new guidance documents were posted to the tracker since its last update.
Registrations for certain transvaginal mesh products are being cancelled by the Australian Therapeutic Goods Administration, and conditions on other mesh and sling products are being imposed.
Check out what B Braun Medical's Anna Maria Braun had to say about how her firm is giving equal importance to every market in Asia-Pacific.
Check out what Covington and Burling's Gina Vetere had to say about US device-makers being locked out of the Trans-Pacific Partnership.
B Braun Medical's Asia-Pacific operations has increasingly grown; sales from the region now makes up the third biggest chunk of the German multinational's annual revenue. But how does a mature company with an extensive portfolio of largely commoditized products stay nimble so it can adapt to a fast-changing and highly fragmented market like APAC? And how does it tackle potential headwinds like competition from local lower-cost manufacturers? Anna Maria Braun, president of B Braun's APAC business, speaks to Medtech Insight about how giving equal importance to every market in APAC – big or small – has helped the company's success in the region, and how innovation and collaboration will play an increasingly large role in ensuring continued growth.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.